NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CureMatch

CureMatch

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.curematch.com/

Last Round

VC Round

Jun 1, 2021

Total Funding Raised

$45,000

Company Overview

CureMatch is a digital health company that provides a decision support system to guide oncologists in the selection of personalized cancer drug combinations based on a patient's molecular tumor profile.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

precision oncologycombination therapyoncology decision supportoncology AIcancer therapy matchingprecision medicinemolecular profiling analysisNGS data interpretationclinical trial intelligencepatient stratificationclinical decision supportCPT code reimbursementnext-generation sequencingNGS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureMatch Comps

Public and private peers based on sector, stage, and business model.

CureMatch comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CureMatch Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 1, 2021
GrantJun 14, 2018
GrantAug 18, 2017
SeedAug 15, 2017

Key People

Founding team and executive leadership

Navid Alipour

Co-Founder CEO Board Member

Founding Team

CureMatch Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2021

    Raised a VC Round with Unitleader as an investor.

  • Jun 14, 2018

    $35K grant received from JPMorgan Chase and World Trade Center San Diego.

CureMatch Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CureMatch Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CureMatch's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range25
Year Founded2015
Last FundingJun 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.